291 related articles for article (PubMed ID: 9058725)
1. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.
Döhner K; Brown J; Hehmann U; Hetzel C; Stewart J; Lowther G; Scholl C; Fröhling S; Cuneo A; Tsui LC; Lichter P; Scherer SW; Döhner H
Blood; 1998 Dec; 92(11):4031-5. PubMed ID: 9834205
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED
Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909
[TBL] [Abstract][Full Text] [Related]
4. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
[TBL] [Abstract][Full Text] [Related]
5. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia.
Johnson EJ; Scherer SW; Osborne L; Tsui LC; Oscier D; Mould S; Cotter FE
Blood; 1996 May; 87(9):3579-86. PubMed ID: 8611680
[TBL] [Abstract][Full Text] [Related]
6. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
7. Delineation of multiple deleted regions in 7q in myeloid disorders.
Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
[TBL] [Abstract][Full Text] [Related]
9. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of a myelodysplasia-associated chromosome 7 inversion.
Todd R; Bia B; Johnson E; Jones C; Cotter F
Br J Haematol; 2001 Apr; 113(1):143-52. PubMed ID: 11328294
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
Stilgenbauer S; Liebisch P; James MR; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11837-41. PubMed ID: 8876224
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
15. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
16. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
Lezon-Geyda K; Najfeld V; Johnson EM
Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
[TBL] [Abstract][Full Text] [Related]
18. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.
Liang H; Fairman J; Claxton DF; Nowell PC; Green ED; Nagarajan L
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3781-5. PubMed ID: 9520444
[TBL] [Abstract][Full Text] [Related]
19. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosome arm 3p in hematologic malignancies.
Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
